Anandamide reduces the migration of lymphocytes to the intestine by CB2 activation and reduces TNF-α in the target organs, protecting mice from graft-versus-host disease.
Eur J Pharmacol
; 956: 175932, 2023 Oct 05.
Article
em En
| MEDLINE
| ID: mdl-37536622
Palavras-chave
AM251 (PubChem CID: 2125); AM630 CB2 antagonist (PubChem CID: 135649929); Anandamide; Anandamide (PubChem CID: 5281969); Cannabinoid receptor 2; Chemical compounds studied in this article; Endocannabinoids; Graft-versus-host disease; Inflammation; JWH133 (PubChem CID: 6918505); MAFP (PubChem CID: 10429254)
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Endocanabinoides
/
Doença Enxerto-Hospedeiro
Limite:
Animals
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article